Safeplus International (ACAI) Stock Price, News & Analysis

Company Overview

Safeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 5 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACAI Stock Analysis - Frequently Asked Questions

How do I buy shares of Safeplus International?

Shares of ACAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Safeplus International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Safeplus International investors own include Merck & Co., Inc. (MRK), Lyft (LYFT), Intel (INTC), Gaming and Leisure Properties (GLPI), Gilead Sciences (GILD), Energy Transfer (ET) and DigitalOcean (DOCN).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 2/28/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ACAI
• CUSIP: N/A
• CIK: N/A
• Web: www.biophan.com
• Phone: 8675526602980
• Fax: 585-427-2433
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 25,380,000
• Free Float: 24,364,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A